Publication:
Administration of Hookworm Excretory/Secretory Proteins Improves Glucose Tolerance in a Mouse Model of Type 2 Diabetes

dc.contributor.authorKhudhair, Zainab
dc.contributor.authorAlhallaf, Rafid
dc.contributor.authorEichenberger, Ramon M
dc.contributor.authorField, Matt
dc.contributor.authorKrause, Lutz
dc.contributor.authorSotillo, Javier
dc.contributor.authorLoukas, Alex
dc.contributor.funderNational Health and Medical Research Council (Australia)es_ES
dc.contributor.funderAustralian Research Counciles_ES
dc.contributor.funderAustralian Institute of Tropical Health and Medicinees_ES
dc.contributor.funderJames Cook University (Australia)es_ES
dc.date.accessioned2022-11-18T10:09:50Z
dc.date.available2022-11-18T10:09:50Z
dc.date.issued2022-04-26
dc.description.abstractDiabetes is recognised as the world's fastest growing chronic condition globally. Helminth infections have been shown to be associated with a lower prevalence of type 2 diabetes (T2D), in part due to their ability to induce a type 2 immune response. Therefore, to understand the molecular mechanisms that underlie the development of T2D-induced insulin resistance, we treated mice fed on normal or diabetes-promoting diets with excretory/secretory products (ES) from the gastrointestinal helminth Nippostrongylus brasiliensis. We demonstrated that treatment with crude ES products from adult worms (AES) or infective third-stage larvae (L3ES) from N. brasiliensis improved glucose tolerance and attenuated body weight gain in mice fed on a high glycaemic index diet. N. brasiliensis ES administration to mice was associated with a type 2 immune response measured by increased eosinophils and IL-5 in peripheral tissues but not IL-4, and with a decrease in the level of IL-6 in adipose tissue and corresponding increase in IL-6 levels in the liver. Moreover, treatment with AES or L3ES was associated with significant changes in the community composition of the gut microbiota at the phylum and order levels. These data highlight a role for N. brasiliensis ES in modulating the immune response associated with T2D, and suggest that N. brasiliensis ES contain molecules with therapeutic potential for treating metabolic syndrome and T2D.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis research was supported by a program grant from the National Health and Medical Research Council (1132975), and a strategic research initiative award from the Australian Research Council to The Australian Institute of Tropical Health and Medicine at James Cook University (SRI40200003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.es_ES
dc.format.number5es_ES
dc.format.page637es_ES
dc.format.volume12es_ES
dc.identifier.citationBiomolecules. 2022 Apr 26;12(5):637.es_ES
dc.identifier.doi10.3390/biom12050637es_ES
dc.identifier.e-issn2218-273Xes_ES
dc.identifier.journalBiomoleculeses_ES
dc.identifier.pubmedID35625566es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15185
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)es_ES
dc.relation.publisherversionhttps://doi.org/10.3390/biom12050637es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectNippostrongyluses_ES
dc.subjectHelminthes_ES
dc.subjectDiabeteses_ES
dc.subjectExcretory/secretory productses_ES
dc.subjectT helper 2es_ES
dc.subjectEosinophilses_ES
dc.subjectM2 macrophagees_ES
dc.subject.meshDiabetes Mellitus, Type 2es_ES
dc.subject.meshInsulin Resistancees_ES
dc.subject.meshAncylostomatoideaes_ES
dc.subject.meshAnimalses_ES
dc.subject.meshDisease Models, Animales_ES
dc.subject.meshGlucosees_ES
dc.subject.meshInterleukin-6es_ES
dc.subject.meshMicees_ES
dc.subject.meshNippostrongyluses_ES
dc.titleAdministration of Hookworm Excretory/Secretory Proteins Improves Glucose Tolerance in a Mouse Model of Type 2 Diabeteses_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication40eca1bb-9f01-4912-99c8-1fc7f0246d5b
relation.isAuthorOfPublication.latestForDiscovery40eca1bb-9f01-4912-99c8-1fc7f0246d5b

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
EffectsHypocalcemicVitaminDAnalogs_2022.pdf
Size:
20.65 MB
Format:
Adobe Portable Document Format
Description: